Cardiovascular effects of captopril and enalapril in obese Zucker rats

European Journal of Pharmacology

Volumn 365, Issue 2-3, 1999, Pages 225-232

  Duarte, Juan ^a   Martinez, Andres ^a   Bermejo, Almudena ^a   Vera, Beatriz ^a   Gámez, Maria José ^a   Cabo, Paloma ^a   Zarzuelo, Antonio ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Aorta; Captopril; Cardiac hypertrophy; Enalapril; Insulin resistance; Zucker rat

Indexed keywords

ACETYLCHOLINE; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; NITROPRUSSIDE SODIUM; NORADRENALIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BLOOD VESSEL REACTIVITY; BODY WEIGHT; CONTROLLED STUDY; DRUG SENSITIVITY; ENDOTHELIUM; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HEART VENTRICLE HYPERTROPHY; INSULIN BLOOD LEVEL; NONHUMAN; OBESITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; RAT;

ACETYLCHOLINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA; BLOOD PRESSURE; CAPTOPRIL; CARDIOMEGALY; DIABETES MELLITUS, TYPE 2; DIAPHRAGM; ENALAPRIL; FEMALE; GLUCOSE; INSULIN; MUSCLE, SKELETAL; NITROPRUSSIDE; NOREPINEPHRINE; ORGAN SIZE; POTASSIUM CHLORIDE; PROTEINURIA; RATS; RATS, ZUCKER;

EID: 0032908388     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00879-6     Document Type: Article

References (54)

1. Anderson E.A., Hoffman R.P., Balon T.W., Sinkey C.A., Mark A.L. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J. Clin. Invest. 87:1991;2246-2252.
2. Bao G., Gohlke P., Qadri F., Unger T. Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril. Hypertension. 20:1992;74-79.
3. proV) and renal hemodynamics in hypertensive type-II diabetic patients with nephropathy (DNH). Hypertension. 17:1991;422.
4. Bohlen H.G., Lash J.M. Endothelial-dependent vasodilation is preserved in non-insulin-dependent Zucker fatty diabetic rats. Am. J. Physiol. 268:1995;H2366-H2374.
5. Bray G.A. The Zucker-fatty rat: a review. Fed. Proc. 36:1977;148-153.
6. Cachofeiro V., Sakakibara T., Nasjletti A. Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension. Hypertension. 19:1992;138-145.
7. Clozel M., Kuhn H., Hefti F. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension. 16:1990;532-540.
8. Cox R.H., Kikta D.C. Age-related changes in thoracic aorta of obese Zucker rats. Am. J. Physiol. 262:1992;H1548-H1556.
9. Creager M.A., Roddy M.-A. Effect of captopril and enalapril on endothelial function in hypertensive patients. Hypertension. 24:1994;499-505.
10. Crettaz M., Prentki M., Zaninetti D., Jeanrenaud B. Insulin resistance in soleus muscle from obese Zucker rats: involvement of several defective sites. Biochem. J. 186:1980;525-534.
11. Duarte J., Pérez-Vizcaíno F., Zarzuelo A., Jimenez J., Tamargo J. Inhibitory effects of quercetin and staurosporine on phasic contractions in rat vascular smooth muscle. Eur. J. Pharmacol. 262:1994;149-156.
12. Dzau V.J. Short- and long-term determinants of cardiovascular function and therapy: contributions of circulating and tissue renin-angiotensin system. J. Cardiovasc. Pharmacol. 14:1989;S1-S5.
13. Erdoes E.G., Skidgel R.A. The unusual substrate specificity and the distribution of human angiotensin I converting enzyme. Hypertension. 8:1986;40-48.
14. Feletou M., Moreau N., Duhault J. Vascular responsiveness in young, diabetic, and aging hyperinsulinemic rats. Life Sciences. 54:1994;1801-1813.
15. Ferrannini E., Buzzigoli G., Giorico M.A. Insulin resistance in essential hypertension. New Engl. J. Med. 31:1987;350-357.
16. Frochlich E., Apstein C., Chobanian A., Devereux R., Dustan H., Dzau V., Fauad-Tarazi F., Horan M., Marcus M., Massie B., Pfefer M., Re R., Roccella E., Savage D., Shub C. The heart in hypertension. New Engl. J. Med. 327:1993;998-1008.
17. Furchgott R.F. Role of endothelium in responses of vascular smooth muscle. Circ. Res. 53:1983;557-573.
18. Furchgott R.F., Vanhoutte P.M. Endothelium-derived relaxing and contracting factors. FASEB J. 3:1989;2007-2018.
19. Harker C.T., Odonnell M.P., Kasiske B.l., Keane W.F., Katz S.A. The renin-angiotensin system in the type-II diabetic obese Zucker rat. J. Am. Soc. Nephrol. 4:1993;1354-1361.
20. Henriksen E.J., Jacob S. Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats. Metabolism. 44:1995;267-273.
21. Henriksen E.J., Jacob S., Augustin H.J., Dietze G.J. Glucose transport activity in insulin-resistant rat muscle. Effects of angiotensin-converting enzyme inhibitors and bradykinin antagonism. Diabetes. 45:1996;S125-S128.
22. Ionescu E., Sauter J.F., Jeanrenaud B. Abnormal oral glucose tolerance in genetically obese (fa/fa) rats. Am. J. Physiol. 248:1985;E500-E506.
23. Kaplan N.M. The deadly quartet. Arch. Intern. Med. 149:1989;1514-1520.
24. Kasiske B.L., Cleary M.P., O'Donnell M.P., Keane W.F. Effects of genetic obesity on renal structure and function in the Zucker rat. J. Lab. Clin. Med. 106:1985;598-604.
25. Kemmer F.W., Berger M., Herberg L., Gries F.A., Wirdeier A., Becker K. Glucose metabolism in perfused skeletal muscle: demonstration of insulin resistance in obese Zucker rat. Biochem. J. 178:1979;733-741.
26. King P.A., Horton E.D., Hirshman M.F., Horton E.S. Insulin resistance in obese Zucker rat (fa/fa) skeletal muscle is associated with a failure of glucose transporter translocation. J. Clin. Invest. 90:1992;1568-1575.
27. Kurtz T.W., Morris R.C., Pershadsingh H.A. The Zucker fatty rat as a genetic model of obesity and hypertension. Hypertension. 13:1989;896-901.
28. Lahera V., Khraiba A.A., Romero J.C. Sulfhydryl group donors potentiate the hypotensive effect of acetylcholine in rats. Hypertension. 22:1993;156-160.
29. Levin B.E., Stoddard-Apter S., Sullican A.C. Central activation and peripheral function of sympatho-adrenal and cardiovascular systems in the Zucker rat. Physiol. Behav. 32:1984;295-299.
30. Linz W., Wiemer G., Gohlke P., Unger T., Schölkens B. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol. Rev. 47:1995;25-49.
31. Lithell H.O.L. Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care. 14:1991;203-209.
32. Lüscher T.F., Vanhoutte P.M. Antihypertensive therapy normalizes endothelium-dependent relaxations in salt-induced hypertension of the rat. Hypertension. 9:1987;193-197. suppl. III.
33. Modan M., Halkin H., Almay S., Lusky A., Eshkil M., Shitrit A., Fuchs A. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J. Clin. Invest. 75:1985;809-817.
34. O'Donnell M.P., Kasiske B.L., Cleary M.P., Keane W.F. Effects of genetic obesity on renal structure and function in the Zucker rat: II. Micropuncture studies. J. Lab. Clin. Med. 106:1985;605-610.
35. Panza J.A., Quyyumi A.A., Callahan T.S., Epstein S.E. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J. Am. Coll. Cardiol. 21:1993;1145-1151.
36. Pawloski C.M., Kanagy N.L., Mortensen L.H., Fink G.D. Obese Zucker rats are normotensive on normal and increased sodium intake. Hypertension. 19:1992;I90-I95.
37. Peuler J.D., Mark A.L. Aggravation of salt-induced hypertension in Dahl rats by 2% supplemental dietary calcium. Hypertension. 13:1989;929-934.
38. Reaven G.M. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
39. Rosenthal T., Erlich Y., Rosenmann E., Cohen A. Effects of enalapril, losartan, and verapamil on blood pressure and glucose metabolism in the Cohen-Rosenthal diabetic hypertensive rat. Hypertension. 29:1997;1260-1264.
40. Schmitz P.G., O'Donnell M.P., Kasiske B.L., Katz S.A., Keane W.F. Renal injury in obese Zucker rats: glomerular hemodynamic alterations and effects of enalapril. Am. J. Physiol. 263:1992;F496-F502.
41. Sherman W.M., Katz A.L., Cutler C.L., Withers R.T., Ivy J.L. Glucose transport: locus of muscle insulin resistance in obese Zucker rats. Am. J. Physiol. 255:1988;E374-E382.
42. Shultz P.J., Raij L. Effects of antihypertensive agents on endothelium-dependent and endothelium-independent relaxations. Br. J. Clin. Pharmacol. 28:1989;1515-1575.
43. Smith R.D., Chiu A.T., Wong P.C., Herblin W.F., Timmermans P. Pharmacology of nonpeptide angiotensin II receptor antagonists. Annu. Rev. Pharmacol. Toxicol. 32:1992;135-165.
44. Tomiyama H., Kushiro T., Abeta H., Ishii T., Takahashi A., Furukawa L., Asagami T., Hino T., Saito F., Otsuka Y., Kurumatani H., Kobayashi F., Kanmatsuse K., Kajiwara N. Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor. Hypertension. 23:1994;450-455.
45. Tschudi M.R., Criscione L., Novosel D., Pfeiffer K., Lüscher T.F. Antihypertensive therapy augments endothelium-dependent relaxations in coronary arteries of spontaneously hypertensive rats. Circulation. 89:1994;2212-2218.
46. Uehara M., Kishikawa H., Isami S., Kisanuki K., Ohkubo Y., Miyamura N., Miyata T., Yano T., Shichiri M. Effects on insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: bradykinin may improve insulin resistance in dogs and humans. Diabetologia. 37:1994;300-307.
47. Waeber B., Brunner H.R. Cardiovascular hypertrophy: role of angiotensin II and bradykinin. J. Cardiovasc. Pharmacol. 27:1996;S36-S40.
48. Vallance-Owen J. Estimation of plasma-insulin by the rat diaphragm method. Lancet. 9:1972;68-70.
49. Walker A.B., Dores J., Buckingham R.E., Savage M.W., Williams G. Impaired insulin induced attenuation of noradrenaline-mediated vasoconstriction in insulin-resistant obese Zucker rats. Clin. Sci. 93:1997;235-241.
50. Wu X., Makynen H., Kahonen M., Arvola P., Porsti I. Mesenteric arterial function in vitro in three models of experimental hypertension. J. Hypertens. 14:1996;365-372.
51. Zarzuelo A., Jiménez I., Gámez M.J., Utrilla P., Fernandez I., Torres M.I., Osuna I. Effects of luteolin 5-O-β-rutinoside in streptozotocin-induced diabetic rats. Life Sciences. 58:1996;2311-2316.
52. Zemel M.B., Reddy S., Shehin S.E., Lockette W., Sowers J.R. Vascular reactivity in Zucker rats: role of insulin resistance. J. Vasc. Med. Biol. 2:1990;81-85.
53. Zemel M.B., Reddy S., Sowers J.R. Insulin attenuation of vasoconstrictor responses to phenylephrine in Zucker lean and obese rats. Am. J. Hypertens. 4:1991;537-539.
54. Zemel M.B., Peuler J.D., Sowers J.R., Simpson L. Hypertension in insulin-resistant Zucker obese rats is independent of sympathetic neural support. Am. J. Physiol. 262:1992;E368-E371.